Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis-Reference-Cited by-同舟云学术

Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis

Published:2010-12-06 Issue:1 Volume:28 Page:51-61
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Tan Hiangkiat,Cai Qian,Agarwal Sonalee,Stephenson Judith J.,Kamat Siddhesh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-010-0093-7.pdf

Reference28 articles.

1. National Multiple Sclerosis Society [online]. 1. Available from URL: http://www.nationalmssociety.org/about-multiple-sclerosis . Accessed March 5, 2010.

2. Frohman EM. Multiple sclerosis. Med Clin North Am. 2003;87:867–868ix.

3. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol. 2006;19:248–254.

4. Goodin DS, Frohman EM, Garmany GP, Jr., et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58:169–178.

5. Lubin F, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology. 2003;61:1528–1532.

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER;Multiple Sclerosis and Related Disorders;2024-10

2. Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09

3. Multiple sclerosis relapse presenting as trigeminal neuralgia;Radiology Case Reports;2024-08

4. Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-05

5. Adherencia al tratamiento en pacientes con esclerosis múltiple: factores de riesgo;Neurología;2024-05